95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.22%
Negative revenue growth while OR stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
1.53%
Gross profit growth of 1.53% while OR is zero. Bruce Berkowitz would see if minimal improvements could expand further.
1.53%
Positive EBIT growth while OR is negative. John Neff might see a substantial edge in operational management.
1.53%
Positive operating income growth while OR is negative. John Neff might view this as a competitive edge in operations.
-15.01%
Negative net income growth while OR stands at 131.13%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.38%
Negative EPS growth while OR is at 131.82%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.38%
Negative diluted EPS growth while OR is at 131.82%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while OR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-7.83%
Negative OCF growth while OR is at 79.48%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-109.37%
Negative FCF growth while OR is at 82.18%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
436.30%
10Y CAGR of 436.30% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
232.88%
5Y CAGR of 232.88% while OR is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
3.23%
3Y CAGR of 3.23% while OR is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
5716.61%
10Y OCF/share CAGR above 1.5x OR's 42.29%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
275.62%
5Y OCF/share CAGR above 1.5x OR's 42.29%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-10.86%
Negative 3Y OCF/share CAGR while OR stands at 42.29%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
355.00%
Similar net income/share CAGR to OR's 370.46%. Walter Schloss would see parallel tailwinds or expansions for both firms.
299.42%
5Y net income/share CAGR at 75-90% of OR's 370.46%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-35.50%
Negative 3Y CAGR while OR is 370.46%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
4976.04%
Equity/share CAGR of 4976.04% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
129.38%
Equity/share CAGR of 129.38% while OR is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
41.54%
Equity/share CAGR of 41.54% while OR is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while OR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-13.59%
Firm’s AR is declining while OR shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
1.98%
Asset growth of 1.98% while OR is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
1.93%
BV/share growth of 1.93% while OR is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-0.04%
We’re deleveraging while OR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
34.32%
SG&A growth well above OR's 41.15%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.